HLA, Immune Response, and Susceptibility to COVID-19
Related Experiment Video
Updated: Nov 20, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Fataneh Tavasolian1, Mohsen Rashidi2, Gholam Reza Hatam3
1Spondylitis Program, Division of Rheumatology, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada.
Insights
Human leukocyte antigen (HLA) alleles and original antigenic sin may explain lower COVID-19 rates in Africa. This research explores how HLA and prior exposures influence susceptibility to SARS-CoV-2 infection.
Area of Science:
- Immunology
- Virology
- Epidemiology
Background:
- The Coronavirus Disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, has seen unexpectedly low case and mortality rates in parts of Africa.
- Individual Human Leukocyte Antigen (HLA) alleles are known to influence susceptibility and severity of viral infections.
Purpose of the Study:
- To propose a theory explaining differential susceptibility or resistance to SARS-CoV-2 infections.
- To investigate the role of HLA antigens and original antigenic sin (OAS) in COVID-19 epidemiology.
- To identify individuals at higher risk for severe COVID-19 and understand regional epidemic variations.
Main Methods:
- Theoretical framework development.
- Analysis of existing literature on HLA, viral peptide presentation, and OAS.
- Hypothesizing interactions between HLA alleles, viral epitopes, and immune memory.
Main Results:
- The proposed theory integrates HLA-restricted viral peptide presentation with the OAS effect.
- This integrated model may explain observed variations in COVID-19 susceptibility and severity.
- Differential HLA allele frequencies and prior viral exposures could account for lower reported COVID-19 impact in certain African populations.
Conclusions:
- HLA-antigen profiles and original antigenic sin are proposed as key factors influencing SARS-CoV-2 outcomes.
- Further research is needed to validate the proposed theory and its implications for public health strategies.
- Understanding these immunological factors can enhance our knowledge of COVID-19 epidemiology and individual risk assessment.
Abstract:
The severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2) that appeared in December 2019 has precipitated the global pandemic Coronavirus Disease 2019 (COVID-19). However, in many parts of Africa fewer than expected cases of COVID-19, with lower rates of mortality, have been reported. Individual human leukocyte antigen (HLA) alleles can affect both the susceptibility and the severity of viral infections. In the case of COVID-19 such an analysis may contribute to identifying individuals at higher risk of the disease and the epidemiological level to understanding the differences between countries in the epidemic patterns. It is also recognized that first antigen exposure influences the consequence of subsequent exposure. We thus propose a theory incorporating HLA antigens, the "original antigenic sin (OAS)" effect, and presentation of viral peptides which could explain with differential susceptibility or resistance to SARS-CoV-2 infections.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Vaccinations
Cell-mediated Immune Responses
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

